Pegging Back Hepatitus C: The Potential of Pegylation

By  

Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. : 37-40

Adis International

Access to resources Recommend Favorite

Hepatitis C Heavyweights: Schering-Plough and Roche are Slugging it Out for Dominance in a Billion-dollar Market

By  

Pharmaceutical Innovation, Vol. 11, Iss. 3, 2002-04 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

Guidelines for the management of hepatitis C

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 329, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Emerging drugs for hepatitis C

By Soriano Vincent   Madejon Antonio   Vispo Eugenia   Labarga Pablo   Garcia-Samaniego Javier   Martin-Carbonero Luz   Sheldon Julie   Bottecchia Marcelle   Tuma Paula   Barreiro Pablo  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite

Telaprevir for the treatment of hepatitis C

By Forestier Nicole   Zeuzem Stefan  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 593-606

Informa Healthcare

Access to resources Recommend Favorite